Now with the added mental stress of a two-year pandemic, “we are seeing more visits to our offices with concerns of anxiety, depression, and more,” Ransone said. That means doctors are submitting more claims with mental health codes, which creates more opportunities for denials. Physicians can appeal these denials or try to collect payment from
Health Secretary Sajid Javid says the findings are “stark” ahead of the report’s publication later. Source link
Researchers find deep inequalities of care for atrial fibrillation patients. Credit: Polina Tankilevitch There are racial and socioeconomic inequalities in the prescribing of oral anticoagulants to reduce stroke risk in people with atrial fibrillation, according to a new study conducted in the UK and publishing June 7 in the open-access journal PLOS Medicine by Alyaa
A new study, led by researchers from the University of California, Irvine, reveals the unique cell-to-cell communication networks that can perpetuate inflammation and prevent repigmentation in patients with vitiligo disease. The study, titled, “Multimodal Analyses of Vitiligo Skin Identifies Tissue Characteristics of Stable Disease,” was published today in JCI Insight. “In this study, we couple
CHICAGO —Targeted therapy achieved significantly higher responses rates and longer progression-free survival (PFS) when compared with standard chemotherapy in pediatric patients with BRAF V600-mutant low-grade gliomas, even those as young as 1 year of age. The findings come from a phase 2 trial in pediatric patients (aged 1-18 years) which compared oral targeted therapy with dabrafenib
Pharmaceutical giant Pfizer Inc. announced Monday it would invest $250 million into its 1,300-acre operations center in West Michigan to produce ingredients for its COVID-19 antiviral pill Paxlovid. The facility in Portage, just south of Kalamazoo, will be the company’s only U.S. facility making medicinal ingredients in the pills. The investment will create 250 jobs
Credit: Unsplash/CC0 Public Domain Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients. The new cancer response subtypes reflect responsiveness to drug treatments and are intended to help clinicians be more precise in how they
In a study of patients with high-risk renal cell carcinoma, those who took the drug everolimus daily for up to one year after surgery lived longer without their disease returning (recurrence-free survival, or RFS) than those who did not take everolimus, although the results narrowly missed the clinical trial’s prespecified level for statistical significance. Improvement
A measles vaccine can protect you for a lifetime. Tetanus gives you about 10 years of cover, while flu vaccines need updating every year. When it comes to Covid-19, we’re still not sure exactly how long protection from the vaccine lasts. BBC Health and Disinformation Reporter Rachel Schraer explains why. Motion graphics by Jacqueline Galvin.
Layoffs have begun to hit the digital health industry as two digital health unicorns said they were cutting staff this week. Cerebral, the embattled mental health startup, confirmed layoffs will occur by July 1. The company said it was restructuring its operations and eliminating a number of positions, although it did not specify how many.
